TNF and systemic sclerosis: Considering the higher rate of malignancy in SSc and the fact that the exact pathophysiology of carcinogenesis in SSc remains poorly understood [15, 20] we aim to investigate the impact of selected serum cytokine levels, including TNFα and FAP, on clinical SSc manifestations, as well as cancer and death prevalence during a five year of follow-up.